Fas/FasL Complex Promotes Proliferation and Migration of Brain Endothelial Cells Via FADD–FLIP–TRAF–NF-κB Pathway

Cell Biochemistry and Biophysics

Volumn 71, Issue 3, 2015, Pages 1319-1323

  Zhang, Chunbing ^a   Gao, Feng ^a   Teng, Fengmeng ^a   Zhang, Mingshun ^b  

^a Jiangsu Province Hosptial of TCM ^*  (China)

^b NANJING MEDICAL UNIVERSITY   (China)

Author keywords

Endothelial cell; FasL; NF b; Proliferation

Indexed keywords

CFLAR PROTEIN, MOUSE; FADD PROTEIN, MOUSE; FAS ANTIGEN; FAS ASSOCIATED DEATH DOMAIN PROTEIN; FAS LIGAND; FAS PROTEIN, MOUSE; FLICE INHIBITORY PROTEIN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; SMALL INTERFERING RNA; TUMOR NECROSIS FACTOR RECEPTOR ASSOCIATED FACTOR; VASCULOTROPIN A;

ANIMAL; APOPTOSIS; BRAIN; CELL MOTION; CELL PROLIFERATION; CYTOLOGY; DEFICIENCY; ENDOTHELIUM CELL; GENETICS; METABOLISM; MOUSE; RNA INTERFERENCE; SECRETION (PROCESS); SIGNAL TRANSDUCTION; SOLUBILITY; UPREGULATION;

ANIMALS; ANTIGENS, CD95; APOPTOSIS; BRAIN; CASP8 AND FADD-LIKE APOPTOSIS REGULATING PROTEIN; CELL MOVEMENT; CELL PROLIFERATION; ENDOTHELIAL CELLS; FAS LIGAND PROTEIN; FAS-ASSOCIATED DEATH DOMAIN PROTEIN; MICE; NF-KAPPA B; RNA INTERFERENCE; RNA, SMALL INTERFERING; SIGNAL TRANSDUCTION; SOLUBILITY; TUMOR NECROSIS FACTOR RECEPTOR-ASSOCIATED PEPTIDES AND PROTEINS; UP-REGULATION; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 84930091241     PISSN: 10859195     EISSN: None     Source Type: Journal    
DOI: 10.1007/s12013-014-0351-4     Document Type: Article

References (20)

1. Fahmy, R. G., Dass, C. R., Sun, L. Q., Chesterman, C. N., & Khachigian, L. M. (2003). Transcription factor Egr-1 supports FGF-dependent angiogenesis during neovascularization and tumor growth. Nature Medicine,9, 1026–1032.
2. Lamalice, L., Le Boeuf, F., & Huot, J. (2007). Endothelial cell migration during angiogenesis. Circulation Research,100, 782–794.
3. Nagata, S., & Golstein, P. (1995). The Fas death factor. Science,267, 1449–1456.
4. Clement, M. V., & Stamenkovic, I. (1994). Fas and tumor necrosis factor receptor-mediate cell death: Similarities and distinctions. Journal of Experimental Medicine,180, 557–567.
5. Richardson, B. C., Lalwani, N. D., Johnson, K. J., & Marks, R. M. (1994). Fas ligation triggers apoptosis in macrophages but not endothelial cells. European Journal of Immunology,24, 2640–2645.
6. Biancone, L., Martino, A. D., Orlandi, V., Conaldi, P. G., Toniolo, A., & Camussi, G. (1997). Development of inflammatory angiogenesis by local stimulation of Fas in vivo. Journal of Experimental Medicine,186, 147–152.
7. Alderson, M. R., Armitage, R. J., Maraskovsky, E., Tough, T. W., Roux, E., Schooley, K., et al. (1993). Fas transduces activation signals in normal human T lymphocytes. Journal of Experimental Medicine,178, 2231–2235.
8. Freiberg, R. A., Spencer, D. M., Choate, K. A., Duh, H. J., Schreiber, S. L., Crabtree, G. R., et al. (1997). Fas signal transduction triggers either proliferation or apoptosis in human fibroblasts. Journal of Investigative Dermatology,108, 215–219.
9. Hyer, M. L., Samuel, T., & Reed, J. C. (2006). The FLIP-side of Fas signaling. Clinical Cancer Research,12, 929–5931.
10. Zhou, L. F., Zhang, M. S., Yin, K. S., Ji, Y., Xie, W. P., Cui, X. F., et al. (2006). Effects of adenoviral gene transfer of mutated IkappaBalpha, a novel inhibitor of NF-kappaB, on human monocyte-derived dendritic cells. Acta Pharmacologica Sinica,27, 609–616.
11. Gu, X. Y., Zhou, L. F., Zhang, M. S., Dai, W. J., Chen, S. Y., He, S. H., et al. (2009). Targeted NF-kappaB inhibition of asthmatic serum-mediated human monocyte-derived dendritic cell differentiation in a transendothelial trafficking model. Cellular Immunology,260, 14–20.
12. Seghezzi, G., Patel, S., Ren, C. J., Gualandris, A., Pintucci, G., Robbins, E. S., et al. (1998). Fibroblast growth factor-2 (FGF-2) induces vascular endothelial growth factor (VEGF) expression in the endothelial cells of forming capillaries: An autocrine mechanism contributing to angiogenesis. Journal of Cell Biology,141, 1659–1673.
13. Herzog, B., Pellet-Many, C., Britton, G., Hartzoulakis, B., & Zachary, I. C. (2011). VEGF binding to NRP1 is essential for VEGF stimulation of endothelial cell migration, complex formation between NRP1 and VEGFR2, and signaling via FAK Tyr407 phosphorylation. Molecular Biology of the Cell,22, 2766–2776.
14. Rossi, B., Angiari, S., Zenaro, E., Budui, S. L., & Constantin, G. (2001). Vascular inflammation in central nervous system diseases: Adhesion receptors controlling leukocyte-endothelial interactions. Journal of Leukocyte Biology,89, 539–556.
15. Folkman, J. (2002). Role of angiogenesis in tumor growth and metastasis. Seminars in Oncology,29, 15–18.
16. Ryan, A. E., Shanahan, F., O’Connell, J., & Houston, A. M. (2006). Fas ligand promotes tumor immune evasion of colon cancer in vivo. Cell Cycle,5, 246–249.
17. Gregory, M. S., Saff, R. R., Marshak-Rothstein, A., & Ksander, B. R. (2007). Control of ocular tumor growth and metastatic spread by soluble and membrane Fas ligand. Cancer Research,67, 11951–11958.
18. Hohlbaum, A. M., Moe, S., & Marshak-Rothstein, A. (2000). Opposing effects of transmembrane and soluble Fas ligand expression on inflammation and tumor cell survival. Journal of Experimental Medicine,191, 1209–1220.
19. Beck, H., & Plate, K. H. (2009). Angiogenesis after cerebral ischemia. Acta Neuropathologica,117, 481–496.
20. Broughton, B. R., Reutens, D. C., & Sobey, C. G. (2009). Apoptotic mechanisms after cerebral ischemia. Stroke,40, e331–e339.